Podcasts

May 2019 Monthly Podcast

Evaluation of Pneumococcal and Tetanus Vaccine Responses in Patients with Rheumatoid Arthritis Receiving Baricitinib: Results from a Long-Term Extension Trial Substudy...

Safety and Efficacy of Tofacitinib For Up to 9.5-Years in The Treatment of Rheumatoid Arthritis: Final Results of a Global, Open-Label, Long-Term Extension Study...

Professor Nash and Professor Combe Interview

Efficacy and Safety Data Based on Historical or Pre-Existing Conditions at Baseline for Patients with Active Rheumatoid Arthritis Who Were Treated with Baricitinib....

April 2019 Monthly Podcast

Efficacy and Safety Data Based on Historical or Pre-Existing Conditions at Baseline for Patients with Active Rheumatoid Arthritis Who Were Treated with Baricitinib...

Tuberculosis, Hepatitis B and Herpes Zoster in Tofacitinib-Treated Patients with Rheumatoid Arthritis...

Professor Nash and Professor Takeuchi Interview

Safety Profile of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis with Over 1.6 Years Median Time in Treatment: An Integrated Analysis of Phase 2 and 3 Trials....

Speciality Podcast - Pain Podcast

Professor McInnes reviews 3 abstracts presented at ACR which analyse the relationship between JAK inhibitors and pain in patients with rheumatoid arthritis.

Click here to download the Powerpoint slides...

March 2019 Monthly Podcast

Baricitinib Induces LDL-C and HDL-C Increases in Rheumatoid Arthritis: A Meta-Analysis of Randomized Controlled Trials...

Network Meta-Analysis of Tofacitinib versus Biologic Treatments in Moderate-to-Severe Rheumatoid Arthritis Patients...